Isolate Data
| Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
| CA1494 | CA38071 | U.S. | 2003 | HIV1 | B | Plasma | None |
Treatment History
| Order | Regimen | Weeks |
| 1 | AZT | 22 |
| 2 | DDI | 6 |
| 3 | 3TC+AZT+IDV | 8 |
| 4 | 3TC+D4T+RTV | 45 |
| 5 | 3TC+D4T+NFV | 12 |
| 6 | 3TC+D4T+RTV+SQV | 19 |
| 7 | 3TC+DDI+NFV+RTV | 23 |
| 8 | D4T+RTV+SQV | 27 |
| 9 | EFV+RTV+SQV | 6 |
| 10 | 3TC+APV+DDI+EFV+NFV | 209 |
RT Sequence
| NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
| D67N, T69D, K70R, M184MI, T215F | K219Q | K101E, Y181YC, G190S | P4S, K20R, V60I, V90VI, K122E, D177E, I178M, Q207E, V245E, A272P, K277R, I293V, E297Q |
| >CA38071| codons 1-300 PISSIETVPVKLKPGMDGPRVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPI FAIKKKNSDRWRKLVDFRELNKRTQDFWEIQLGIPHPAGLEKKKSVTVLDVGDAYFSVPL DEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFRKQNPEMVI CQYIDDLYVSSDLEIGQHRTKIEELREHLLRWGFFTPDQKHQKEPPFLWMGYELHPDKWT VQPIELPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVVPLTQEAE |
Protease Sequence
| PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
| G48V, I54V, V82A, L90M | L10I, R57K, L63P, A71V, T74S, V77I, I93L |
| >CA38070| codons 1-99 PQITLWQRPIVTIKIGGQLKEALLDTGADDTVLEEMNLPGRWKPKMIVGIGGFVKVKQYD QIPIEICGHKVIGSVLIGPTPANIIGRNLMTQLGCTLNF |
References
| Author | Title | Citation |
| Rhee, SY | HIV-1 Protease and Reverse Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance. | J Infect Dis, 2005 |
| Melikian, GL | Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility. | AAC, 2012 |